THE FDA AUTHORIZED A PILL TO TREAT COVID

Pfizer is buying a biopharmaceutical company that works on cardiovascular and inflammatory medicines... It's a curious purchase, considering that one of the most prevalent side-effects of Pfizer's covid vaccine is heart inflammation. <br /><br />Sounds like Pfizer is double-dipping on profits: Make money off the vaccine that causes heart inflammation. Then make more money off treatments for the inflammation you caused.<br /><br />Gross.<br /><br /><a href="https://thenationalpulse.com/2021/12/20/pfizer-is-buying-a-cardiovascular-biopharma-company-for-6-7bn" rel="noopener">https://thenationalpulse.com/2021/12/20/pfizer-is-buying-a-cardiovascular-biopharma-company-for-6-7bn</a><br /><br /><br />THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE'S WHAT WE KNOW ABOUT IT<br /><br />The Food and Drug Administration (FDA) just approved the first pill to treat newly infected Covid patients, and it can be taken from the comfort of your own home. The pill has been proven to fight off the worst effects of the virus. <br /><br />The pill is called Paxlovid and is created by Pfizer. The FDA authorization allows doctors to prescribe Paxlovid for high-risk patients, ages 12 and over. Clinical trials show it's most effective if taken in the first five days that symptoms arise.<br /><br />It's only going to high-risk patients right now because there is a limited supply: roughly 60,000 courses available in the U.S. But they anticipate having 250,000 available by the end of January.<br />The major benefit to taking this pill as opposed to some of the other therapeutic treatments that are currently available is that you don't need to be in a clinical setting to take it and it doesn't require an IV or injection. Paxlovid is just three pills taken twice a day for five days at home.<br /><br />Clinical trials found that the pill cut hospitalizations and deaths by 89% when given to people with mild-to-moderate Covid within three days of symptoms arising. <br /><br />It also found:<br />Less than 1% of patients were hospitalized and none die